Trends in indications and outcomes of liver transplantation in Canada
| Autor: | Gonzalo Sapisochin, Bettina E. Hansen, Nazia Selzner, Peter Yoon, Chaya Shwaartz, David Wallace, Carla Fiorella Murillo Perez, Hala Muaddi, Nathanael Raschzok, Madhukar S. Patel, Marco P. A. W. Claasen, Tommy Ivanics |
|---|---|
| Přispěvatelé: | Surgery |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Adult
Canada Transplantation medicine.medical_specialty Carcinoma Hepatocellular Orthotopic liver transplantation Adult patients business.industry medicine.medical_treatment Graft Survival Liver Neoplasms Retrospective cohort study Liver transplantation medicine.disease Liver Transplantation Liver disease Treatment Outcome Internal medicine medicine Etiology Humans Graft survival business Retrospective Studies |
| Zdroj: | Transplant International, 34(8), 1444-1454. Wiley-Blackwell Publishing Ltd |
| ISSN: | 0934-0874 |
| DOI: | 10.1111/tri.13903 |
| Popis: | The liver transplantation (LT) landscape is continuously evolving. We sought to evaluate trends in indications for LT in Canada and the impact of primary liver disease on post-LT outcomes using a national transplant registry. Adult patients who underwent a primary LT between 2000 and 2018 were retrospectively identified in the Canadian Organ Replacement Registry. Outcomes included post-LT patient and graft survival. A total of 5,722 LTs were identified. The number of LT per year increased from 251 in 2000 to 349 in 2018. The proportion of patients transplanted for HCV decreased from 31.5% in 2000 to 3.4% in 2018. In contrast, the percentage of transplants for HCC increased from 2.3% in 2000 to 32.4% in 2018, and those performed for NASH increased from 0.4% in 2005 to 12.6% in 2018. Year of transplant (per 1 year) was protective for both patient (HR:0.96,95%CI:0.94-0.97; P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text